Replies to post #1493 on Vascular Biogenics Ltd (VBLT)

[gr8db8]

Oren ... the way I understand mOS and 12-mo survival is as follows. VB-111's 12-month overall survival is 57% and its median OS is 59 weeks (over 12 months). This is why I was confused why you predict that mOS would be OK but the 12-month survival would be extraordinary.